The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2012
At a glance
- Drugs Capadenoson (Primary)
- Indications Angina pectoris
- Focus Pharmacodynamics
- 01 Jul 2012 Results published in Clinical Research in Cardiology.
- 05 Nov 2010 New trial record.